Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

2.46
Delayed Data
As of 3:59pm ET
 +0.07 / +2.93%
Today’s Change
1.98
Today|||52-Week Range
5.42
-10.22%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close2.39
Today’s open2.41
Day’s range2.39 - 2.50
Volume462,107
Average volume (3 months)835,995
Market cap$158.9M
Dividend yield--
Data as of 3:59pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)+61.81%
Earnings growth (this year)-82.73%
Earnings growth (next 5 years)--
Revenue growth (last year)-66.67%
P/E ratioNM
Price/Sales1,489.77
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
ASTAsterias Biotherapeu...+0.60+14.49%
PSTIPluristem Therapeuti...-0.01-0.51%
CURNeuralstem Inc-0.05-3.31%
PLXProtalix Biotherapeu...+0.01+0.68%
Data as of 4:03pm ET, 08/31/2015

Financials

Next reporting dateOctober 27, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$100.0K
Annual profit (last year)-$30.1M
Net profit margin-30,117.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts

Partner Offers